Dementia Patients Often Get Harmful, Expensive and Unnecessary Drugs: Study
A new study reveals that most dementia patients are given drugs with questional benefits that cost hundreds of dollars a month.
A new study reveals that most dementia patients are given drugs with questional benefits that cost hundreds of dollars a month.
The FDA has denied a petition filed by a consumer group, which had urged the federal drug regulators to ban Aricept 23, a high dose version of the top selling…
The consumer watchdog group Public Citizen has filed a lawsuit against the FDA, seeking to force the federal drug regulatory agency to act on a petition filed to recall approval…
The prominent consumer watchdog Public Citizen is calling for a recall of Aricept 23 milligram, arguing that the higher dose of the medication used to treat Alzheimer’s disease lacks effectiveness…